# OR4D6

## Overview
The OR4D6 gene encodes the olfactory receptor family 4 subfamily D member 6, a protein that belongs to the G-protein-coupled receptor (GPCR) superfamily. This receptor is primarily involved in the detection of odor molecules, playing a significant role in the olfactory system by binding to specific odorants, such as the polycyclic musk compound Galaxolide (Li2021From). The OR4D6 protein is expressed in the olfactory epithelium and contributes to the diversity of olfactory perception, with genetic variations in the gene influencing the intensity of odor perception (Li2021From). Beyond its sensory function, OR4D6 has been identified as a potential therapeutic target in cancer research, where its inhibition may enhance the efficacy of certain cancer treatments (Gilad2021A). This dual role in both olfactory perception and cancer biology underscores the multifaceted importance of the OR4D6 gene and its encoded protein.

## Structure


## Function
The OR4D6 gene encodes an olfactory receptor protein that is part of the G-protein-coupled receptor (GPCR) family, which plays a crucial role in the detection of odor molecules. This receptor is primarily expressed in the olfactory epithelium, where it binds to specific odorants, contributing to the diversity of olfactory detection. OR4D6 is specifically associated with the perception of musk odors, particularly the polycyclic musk compound Galaxolide. Genetic variations in OR4D6, such as the missense SNPs M263T and S151T, have been linked to differences in the intensity perception of Galaxolide, although not its pleasantness (Li2021From). These variations can lead to specific anosmia, where individuals homozygous for certain OR4D6 variants may be unable to perceive Galaxolide (Li2021From).

The receptor's involvement in musk odor perception highlights its role in the broader mechanism of olfactory coding, where differential activation of olfactory receptors results in varied perceptual experiences (Li2021From). Despite strong genetic associations, functional assays have not shown a direct response to Galaxolide in OR4D6, suggesting a complex mechanism of olfactory perception that may involve other proteins or pathways (Li2021From).

## Clinical Significance
The OR4D6 gene has been implicated in various clinical contexts, particularly in cancer and olfactory perception. In cancer research, OR4D6 has emerged as a potential therapeutic target. Studies using genome-wide CRISPR-Cas9 screens have identified OR4D6 as a gene whose inhibition can sensitize breast cancer cells, such as MCF-7, to the SRC-3 inhibitor SI-12. This suggests that OR4D6 may play a role in tumorigenesis and could be targeted to enhance cancer treatment efficacy (Gilad2021A). Although OR4D6 has not been previously associated with cancer progression, its knockdown has shown significant increases in drug sensitivity, indicating its potential as a novel target in cancer therapy (Gilad2021A).

In the realm of olfactory perception, OR4D6 is linked to the perception of musk odors, specifically Galaxolide. Genetic variations in OR4D6, such as missense SNPs, have been associated with decreased intensity perception of this musk compound, suggesting that mutations in OR4D6 can lead to specific anosmia for certain musk odors (Li2021From). These findings highlight the gene's role in both cancer biology and sensory perception.


## References


1. (Li2021From) From musk to body odor: decoding olfaction through genetic variation. This article has 1 citations.

[2. (Gilad2021A) Yosi Gilad, Yossi Eliaz, Yang Yu, Adam M. Dean, San Jung Han, Li Qin, Bert W. Oâ€™Malley, and David M. Lonard. A genome-scale crispr cas9 dropout screen identifies synthetically lethal targets in src-3 inhibited cancer cells. Communications Biology, March 2021. URL: http://dx.doi.org/10.1038/s42003-021-01929-1, doi:10.1038/s42003-021-01929-1. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-021-01929-1)